Hypersensitivity and vaccines: An update

European Journal of Dermatology

Volumn 23, Issue 2, 2013, Pages 135-141

  Barbaud, Annick ^a   Deschildre, Antoine ^b   Waton, Julie ^a   Raison Peyron, Nadia ^c   Tréchot, Philippe ^d  

^a CHU NANCY BRABOIS   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL SAINT ELOI   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Aluminum allergy; Anti flu vaccination; Anti influenza A H1N1 vaccination; BCG; Egg allergy; Hepatitis B vaccination induced urticaria; Vaccines; Vasculitis; Yellow fever vaccination

Indexed keywords

2 PHENOXYETHANOL; ALUMINUM SALT; BCG VACCINE; CHICKENPOX VACCINE; DEXTRAN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GELATIN; HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS VACCINE; IMMUNOGLOBULIN E; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; OVALBUMIN; RECOMBINANT HEPATITIS B VACCINE; SSI; TETANUS TOXOID; UNCLASSIFIED DRUG; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ABNORMAL RESPIRATORY SOUND; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTHRALGIA; ATOPY; BCG VACCINATION; BLOOD PRESSURE; CLINICAL PRACTICE; COUGHING; DELAYED HYPERSENSITIVITY; DIPHTHERIA TETANUS POLIOMYELITIS VACCINATION; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPNEA; ECZEMA; EGG ALLERGY; ERYTHEMA; ERYTHEMA NODOSUM; GRANULOMA; HEPATITIS B VACCINATION; HOT FLUSH; HUMAN; HUMAN PAPILLOMA VIRUS VACCINATION; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; INFLAMMATION; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; LEUKOCYTOCLASTIC VASCULITIS; MACULOPAPULAR RASH; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATCH TEST; PRICK TEST; PRURITUS; PURPURA; PYODERMA GANGRENOSUM; REVIEW; RHONCHI; SACCHAROMYCES CEREVISIAE; SEASONAL INFLUENZA VACCINATION; SIDE EFFECT; SKIN MANIFESTATION; TUBERCULOSIS; URTICARIA; VACCINATION; VACCINATION REACTION; VACCINE PRODUCTION; VASCULITIS; YELLOW FEVER VACCINATION;

ALUMINUM ALLERGY; ANTI-FLU VACCINATION; ANTI-INFLUENZA A H1N1 VACCINATION; BCG; EGG ALLERGY; HEPATITIS B VACCINATION-INDUCED URTICARIA; VACCINES; VASCULITIS; YELLOW FEVER VACCINATION;

ALUMINUM; BCG VACCINE; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG ERUPTIONS; EGG HYPERSENSITIVITY; EXCIPIENTS; GRANULOMA; HEPATITIS B VACCINES; HUMANS; INFLUENZA VACCINES; PAPILLOMAVIRUS VACCINES; SKIN DISEASES; VACCINES; VASCULITIS; YELLOW FEVER VACCINE;

EID: 84877799781     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1842     Document Type: Review

References (39)

1. Barbaud A, Schmutz JL, Mougeolle JM. Réactions immunoallergiques cutanées dues aux vaccins. Ann Dermatol Venereol 1995; 122: 129-138.
2. Ponvert C, Scheinmann P. Vaccine allergy and pseudo-allergy. Eur J Dermatol 2003; 13: 10-15.
3. McKeever TM, Lewis SA, Smith C, Hubbard R. Vaccination and allergic disease: a birth cohort study. Am J Public Health 2004; 94: 985-989.
4. Bergfors E, Trollfors B, Inerot A. Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer. Vaccine 2003; 22: 64-69.
5. Brightman C, Scadding G, Dumbreck L, Latchman Y, Brostoff J. - Yeast-derived hepatitis B vaccine and yeast sensitivity. Lancet 1989; i: 903.
6. Zuo L. A child with gelatin hypersensitivity and anaphylaxis to both jelly beans and MMR/varicella vaccines. 2009 annual meeting of the American college of Allergy, Asthma and Immunology poster 3, (http:/www.acaai.org).
7. Toh J, Jariwala SP, Hudes G, Rosenstreich D. Anaphylaxis after varicella vaccination. 2009 annual meeting of the American college of Allergy, Asthma and Immunology, poster 304.(http:/www.acaai.org).
8. Kelso JM, Jones RT, Yunginger JW. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. Yunginger JW. J Allergy Clin Immunol 1993; 91: 867-872.
9. Leventhal JS, Berger EM, Brauer JA, Cohen DE. Hypersensitivity reactions to vaccine constituents: a case series and review of the literature. Dermatitis 2012; 23: 102-109.
10. Nakayama T, Aizawa C, Kuno-Sakai H. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol 1999; 103: 321-325.
11. Fabry H. Formaldehyde sensitivity. Two interesting cases. Contact Derm Newsletter 1968; 3: 51.
12. Ring J. Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patients. Lancet 1986; 2: 522-523.
13. Rancé F, Grandmottet X, Grandjean H. Prevalence and main characteristics of schoolchildren diagnosed with food allergies in France. Clin Exp Allergy 2005; 35: 167-172.
14. Taylor SL, Hefle SL, Bindslev-Jensen C, et al. Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol 2002; 109: 24-30.
15. Waibel KH, Gomez R. Ovalbumin content in 2009 to 2010 seasonal and H1N1 monovalent influenza vaccines. J Allergy Clin Immunol 2010; 125: 749-751.
16. James JM, Burks AW, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med 1995. 11; 332: 1262-1266.
17. Gagnon R, Primeau MN, Des Roches A, et al. PHAC-CIHR Influenza Research Network. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. Allergy Clin Immunol 2010; 126: 317-323.
18. Roukens AH, Vossen AC, van Dissel JT, Visser LG. Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy. Vaccine 2009; 27: 2408-2409.
19. McKinney KK, Webb L, Petersen M, Nelson M, Laubach S. Ovalbumin content of 2010-2011 influenza vaccines. Allergy Clin Immunol 2011; 127: 1629-1632.
20. Afshar M, Morris-Jones R. A novel approach to the management of inflammatory bacille Calmette-Guérin reactions using topical steroids. Br J Dermatol 2011; 164: 1402-1403.
21. Rudin C, Günthard J, Halter C, Staehelin J, Berglund A. Anaphylactoid reaction to BCG vaccine containing high molecular weight dextran. Eur J Pediatr 1995; 154: 941-942.
22. Arnoldussen DL, Linehan M, Sheikh A. BCG vaccination and allergy: a systematic review and meta-analysis. J Allergy Clin Immunol 2011; 127: 246-253.
23. Barbaud A. Réactions cutanées retardées dues aux vaccins. In Vaccins: intolérance et allergie, John Libbey Eurotext, Montrouge (F), 2003:123-143.
24. Jacobs R, Lowe R, Lanier B. Adverse reactions to tetanus toxoid. J Am Med Assoc 1982; 24: 40-42.
25. Hofman T, Cranswick N, Kuna P, et al. International Tacrolimus Ointment Study Group. Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Arch Dis Child 2006; 91: 905-910.
26. DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; V.A.E.R.S. Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 2006; 24: 703-707.
27. Ebo DG, Bridts CH, Stevens WJ. IgE-mediated large local reaction from recombinant hepatitis B vaccine. Allergy 2008; 63: 483-484.
28. Barbaud A, Tréchot P, Reichert-Pénétrat S, Weber M, Schmutz JL. Allergic mechanisms and urticaria/angioedema after hepatitis B immunization. Br J Dermatol 1998; 139: 925-926.
29. Barbaud A, Reichert-Pénétrat S, Béné MC, et al. Mécanisme immuno-pathologiques en cause dans un cas pédiatrique d'urticaire survenue lors de la primo-vaccination par vaccin anti-hépatite B. Ann Dermatol Venereol 2000; 127: 662-663.
30. Watanabe T. Henoch-Schönlein purpura following influenza vaccinations during the pandemic of influenza A (H1N1). Pediatr Nephrol 2011; 26: 795-798.
31. Caillet C, Durrieu G, Jacquet A, et al. The French Network of Pharmacovigilance Centres. Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France. Eur J Clin Pharmacol 2011; 67: 649-651.
32. Siret-Alatrista A, Bouali F, Demoly M, Bousquet PJ, Demoly P. The 2009-2010 H1N1 vaccination campaign for patients with egg allergy in a region of France. Allergy 2011; 66: 298-299.
33. Gagnon R, Primeau MN, Des Roches A, et al. PHAC-CIHR Influenza Research Network. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J Allergy Clin Immunol 2010; 126: 317-323.
34. Hughes R, Lacour JP, Baldin B, Reverte M, Ortonne JP, Passeron T. Urticarial vasculitis secondary to H1N1 vaccination. Acta Derm Venereol 2010; 90: 651-652.
35. Lindsey NP, Schroeder BA, Miller ER, et al. Adverse event reports following yellow fever vaccination. Vaccine 2008. 11; 26: 6077-6082.
36. Kang LW, Crawford N, Tang ML, et al. Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study. BMJ 2008; 337: a2642.
37. Brotherton JM, Gold MS, Kemp AS, McIntyre PB, Burgess MA, Campbell-Lloyd S; New SouthWales Health HPV Adverse Events Panel. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 2008; 179: 525-533.
38. Halsey NA. The human papillomavirus vaccine and risk of anaphylaxis. CMAJ 2008; 179: 509-510.
39. Katoulis AC, Liakou A, Bozi E, et al. Erythema multiforme following vaccination for human papillomavirus. Dermatology 2010; 220: 60-62.